$3.8 Million Funds Houston Methodist's Chikungunya Vaccine Research

In COVID-19, Latest News by Precision Vaccinations

Scientists at the Houston Methodist Research Institute recently received $3.8 million to develop further a promising type of disease-defense technology that could pave the way for new 'circular RNA' vaccines.
The Coalition for Epidemic Preparedness Innovations (CEPI) announced on January 25, 2024, that it is teaming up with the Houston Methodist vaccinology team to advance its 'circRNA' vaccine development platform.

Read More